BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 1517574)

  • 1. A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei.
    Weiss WR; Berzofsky JA; Houghten RA; Sedegah M; Hollindale M; Hoffman SL
    J Immunol; 1992 Sep; 149(6):2103-9. PubMed ID: 1517574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii.
    Grillot D; Michel M; Müller I; Tougne C; Rènia L; Mazier D; Corradin G; Lambert PH; Louis JA; Del Guidice G
    Eur J Immunol; 1990 Jun; 20(6):1215-22. PubMed ID: 1695152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein.
    Takita-Sonoda Y; Tsuji M; Kamboj K; Nussenzweig RS; Clavijo P; Zavala F
    Exp Parasitol; 1996 Nov; 84(2):223-30. PubMed ID: 8932772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria.
    Romero P; Maryanski JL; Corradin G; Nussenzweig RS; Nussenzweig V; Zavala F
    Nature; 1989 Sep; 341(6240):323-6. PubMed ID: 2477703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
    J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. Evidence that two peptide residues are buried in the MHC molecule.
    Romero P; Eberl G; Casanova JL; Cordey AS; Widmann C; Luescher IF; Corradin G; Maryanski JL
    J Immunol; 1992 Mar; 148(6):1871-8. PubMed ID: 1541825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides.
    Franke ED; Corradin G; Hoffman SL
    J Immunol; 1997 Oct; 159(7):3424-33. PubMed ID: 9317141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
    White KL; Snyder HL; Krzych U
    J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.
    Meraldi V; Romero JF; Kensil C; Corradin G
    Vaccine; 2005 Apr; 23(21):2801-12. PubMed ID: 15780728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CTL epitope on the circumsporozoite protein of P. yoelii.
    Weiss WR; Houghten RA; Good MF; Berzofsky JA; Miller LH; Hoffman SL
    Bull World Health Organ; 1990; 68 Suppl(Suppl):99-103. PubMed ID: 1709838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection.
    Douradinha B; van Dijk MR; Ataide R; van Gemert GJ; Thompson J; Franetich JF; Mazier D; Luty AJ; Sauerwein R; Janse CJ; Waters AP; Mota MM
    Int J Parasitol; 2007 Nov; 37(13):1511-9. PubMed ID: 17604034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages.
    Rénia L; Grillot D; Marussig M; Corradin G; Miltgen F; Lambert PH; Mazier D; Del Giudice G
    J Immunol; 1993 Feb; 150(4):1471-8. PubMed ID: 7679428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of hepatic inflammatory response by Plasmodium berghei sporozoites protects BALB/c mice against challenge with Plasmodium yoelii sporozoites.
    Vanderberg JP; Khan ZM; Stewart MJ
    J Parasitol; 1993 Oct; 79(5):763-7. PubMed ID: 8410550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.
    Rodrigues M; Li S; Murata K; Rodriguez D; Rodriguez JR; Bacik I; Bennink JR; Yewdell JW; Garcia-Sastre A; Nussenzweig RS
    J Immunol; 1994 Nov; 153(10):4636-48. PubMed ID: 7525709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.
    Doolan DL; Hoffman SL
    J Immunol; 1999 Jul; 163(2):884-92. PubMed ID: 10395683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
    Hetttihewa LM
    Int Immunopharmacol; 2003 Oct; 3(10-11):1401-11. PubMed ID: 12946436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria.
    Rodrigues MM; Cordey AS; Arreaza G; Corradin G; Romero P; Maryanski JL; Nussenzweig RS; Zavala F
    Int Immunol; 1991 Jun; 3(6):579-85. PubMed ID: 1716146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.
    Tartz S; Kamanova J; Simsova M; Sebo P; Bolte S; Heussler V; Fleischer B; Jacobs T
    Infect Immun; 2006 Apr; 74(4):2277-85. PubMed ID: 16552058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the antigens of invasive stages of Plasmodium yoelii and Plasmodium berghei].
    Jin LQ; Luo JM; Fu YC; Xu SE; Guo Y; Xie LC; Tsuboi T; Torii M
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2003; 21(5):272-4. PubMed ID: 15108514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.